• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 A5 控制果糖诱导的小鼠代谢紊乱。

Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.

机构信息

Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria; Christan Doppler Laboratory for Metabolic Crosstalk, Department of Medicine I, Medical University of Innsbruck, Innsbruck, Austria.

Institut Pasteur de Lille, CHU Lille, Univ. Lille - EGID, Lille, France.

出版信息

Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):972-978. doi: 10.1016/j.numecd.2020.11.008. Epub 2020 Nov 17.

DOI:10.1016/j.numecd.2020.11.008
PMID:33549451
Abstract

BACKGROUND AND AIMS

Western dietary habits are partially characterized by increased uptake of fructose, which contributes to metabolic dysregulation and associated liver diseases. For example, a diet enriched with fructose drives insulin resistance and non-alcoholic fatty liver disease (NAFLD). The molecular hubs that control fructose-induced metabolic dysregulation are poorly understood. Apolipoprotein A5 (apoA5) controls triglyceride metabolism with a putative role in hepatic lipid deposition. We explored apoA5 as a rheostat for fructose-induced hepatic and metabolic disease in mammals.

METHODS AND RESULTS

ApoA5 knock out (-/-) and wildtype (wt) mice were fed with high fructose diet or standard diet for 10 weeks. Afterwards, we conducted a metabolic characterization by insulin tolerance test as well as oral glucose tolerance test. Additionally, hepatic lipid content as well as transcription patterns of key enzymes and transcription factors in glucose and lipid metabolism were evaluated. Despite comparable body weight, insulin sensitivity was significantly improved in high fructose diet fed apoA5 (-/-) when compared to wildtype mice on the same diet. In parallel, hepatic triglyceride content was significantly lower in apoA5 (-/-) mice than in wt mice. No difference was seen between apoA5 (-/-) and wt mice on a standard diet.

CONCLUSION

ApoA5 is involved in fructose-induced metabolic dysregulation and associated hepatic steatosis suggesting that apoA5 may be a novel target to treat metabolic diseases.

摘要

背景与目的

西方饮食习惯的特点之一是果糖摄取量增加,这导致了代谢失调和相关的肝脏疾病。例如,富含果糖的饮食会导致胰岛素抵抗和非酒精性脂肪性肝病(NAFLD)。控制果糖诱导的代谢失调的分子枢纽尚未得到充分理解。载脂蛋白 A5(apoA5)控制甘油三酯代谢,在肝脏脂质沉积中可能具有作用。我们探讨了 apoA5 作为哺乳动物果糖诱导的肝脏和代谢疾病的变阻器。

方法和结果

apoA5 敲除(-/-)和野生型(wt)小鼠分别用高果糖饮食或标准饮食喂养 10 周。然后,我们通过胰岛素耐量试验和口服葡萄糖耐量试验进行代谢特征分析。此外,评估了肝脂质含量以及葡萄糖和脂质代谢关键酶和转录因子的转录模式。尽管体重相当,但与同饮食的野生型小鼠相比,高果糖饮食喂养的 apoA5(-/-)小鼠的胰岛素敏感性显著改善。与此同时,apoA5(-/-)小鼠的肝甘油三酯含量明显低于 wt 小鼠。在标准饮食下,apoA5(-/-)和 wt 小鼠之间没有差异。

结论

apoA5 参与果糖诱导的代谢失调和相关的肝脂肪变性,表明 apoA5 可能是治疗代谢疾病的新靶点。

相似文献

1
Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.载脂蛋白 A5 控制果糖诱导的小鼠代谢紊乱。
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):972-978. doi: 10.1016/j.numecd.2020.11.008. Epub 2020 Nov 17.
2
Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.奥氮平通过抑制载脂蛋白 A5 的分泌引起非酒精性脂肪性肝病。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):730-738. doi: 10.11817/j.issn.1672-7347.2022.210269.
3
APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.载脂蛋白C3蛋白并非小鼠脂肪诱导的非酒精性脂肪性肝病的诱发因素。
J Biol Chem. 2017 Mar 3;292(9):3692-3705. doi: 10.1074/jbc.M116.765917. Epub 2017 Jan 23.
4
ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.载脂蛋白A5基因敲低通过减少异位脂质含量改善高脂喂养小鼠的全身胰岛素敏感性。
J Lipid Res. 2015 Mar;56(3):526-536. doi: 10.1194/jlr.M054080. Epub 2014 Dec 29.
5
Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.特定氨基酸对果糖诱导的非酒精性脂肪性肝病肝脏脂质代谢的影响。
Clin Nutr. 2016 Feb;35(1):175-182. doi: 10.1016/j.clnu.2015.01.021. Epub 2015 Feb 11.
6
Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.载脂蛋白 A5 基因多态性与非酒精性脂肪性肝病相关。
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):214-219. doi: 10.1016/j.hbpd.2018.04.004. Epub 2018 Apr 21.
7
The role of apolipoprotein A5 in non-alcoholic fatty liver disease.载脂蛋白 A5 在非酒精性脂肪性肝病中的作用。
Gut. 2011 Jul;60(7):985-91. doi: 10.1136/gut.2010.222224. Epub 2011 Feb 21.
8
Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters.载脂蛋白 A5 的耗竭通过降低仓鼠肝脏中的 NR1D1 加剧自发性和饮食诱导的非酒精性脂肪肝疾病。
Theranostics. 2024 Feb 24;14(5):2036-2057. doi: 10.7150/thno.91084. eCollection 2024.
9
Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.整合组学分析揭示高果糖玉米糖浆在肥胖型非酒精性脂肪肝病中的作用。
Metabolism. 2023 Jul;144:155552. doi: 10.1016/j.metabol.2023.155552. Epub 2023 Mar 28.
10
Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.叶黄素对大鼠非酒精性脂肪性肝病的改善作用。
World J Gastroenterol. 2015 Jul 14;21(26):8061-72. doi: 10.3748/wjg.v21.i26.8061.

引用本文的文献

1
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.动脉粥样硬化中的甘油三酯及富含甘油三酯的脂蛋白
Front Mol Biosci. 2022 May 25;9:909151. doi: 10.3389/fmolb.2022.909151. eCollection 2022.